Fx-1006A Completed Phase 1 Trials for Moderate Hepatic Dysfunction / Mild Hepatic Dysfunction Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01358565Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction